BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng Z, Wu J, Liu X, Zhou W, Ni M, Liu S, Guo S, Jia S, Zhang J. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis. J Int Med Res 2020;48:300060520910019. [PMID: 32722976 DOI: 10.1177/0300060520910019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Kakar MU, Mehboob MZ, Akram M, Shah M, Shakir Y, Ijaz HW, Aziz U, Ullah Z, Ahmad S, Ali S, Yin Y, Li K. Identification of Differentially Expressed Genes Associated with the Prognosis and Diagnosis of Hepatocellular Carcinoma by Integrated Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/4237633] [Reference Citation Analysis]
2 Mu W, Xie Y, Li J, Yan R, Zhang J, Liu Y, Fan Y. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma. World J Surg Oncol 2022;20:22. [PMID: 35065633 DOI: 10.1186/s12957-021-02479-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Liang F, Peng L, Ma YG, Hu W, Zhang WB, Deng M, Li YM. Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data. Exp Ther Med 2022;23:6. [PMID: 34815758 DOI: 10.3892/etm.2021.10928] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang J, Zhang Q, Shi F, Yadav DK, Hong Z, Wang J, Liang T, Bai X. A Seven-Gene Signature to Predict Prognosis of Patients With Hepatocellular Carcinoma. Front Genet 2021;12:728476. [PMID: 34603388 DOI: 10.3389/fgene.2021.728476] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Hao L, Li S, Peng Q, Guo Y, Ji J, Zhang Z, Xue Y, Liu Y, Shi X. Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer. Oncol Lett 2021;22:653. [PMID: 34386075 DOI: 10.3892/ol.2021.12914] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
6 Zhang P, Feng J, Wu X, Chu W, Zhang Y, Li P. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases. Pathol Oncol Res 2021;27:588532. [PMID: 34257537 DOI: 10.3389/pore.2021.588532] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
7 Liu R, Wang G, Zhang C, Bai D. A prognostic model for hepatocellular carcinoma based on apoptosis-related genes. World J Surg Oncol 2021;19:70. [PMID: 33712023 DOI: 10.1186/s12957-021-02175-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhang H, Liu R, Sun L, Guo W, Ji X, Hu X. Comprehensive Analysis of Gene Expression Changes and Validation in Hepatocellular Carcinoma. Onco Targets Ther 2021;14:1021-31. [PMID: 33623390 DOI: 10.2147/OTT.S294500] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]